Business Wire

Owl Labs partners with Westcoast to expand access to seamless hybrid meeting experiences in the UK and Ireland

11.5.2026 09:00:00 CEST | Business Wire | Press Release

Share

Owl Labs, a global leader in AI-powered, 360-degree video conferencing solutions, today announced a new UK and Ireland distribution partnership with Westcoast Limited, one of the country’s largest and most trusted IT distributors. The agreement will see Westcoast distribute the full range of Owl Labs’ award-winning Meeting Owl and Owl Bar products across the UK and Ireland, providing greater choice, availability, and dedicated support for resellers and end customers navigating the demands of hybrid work.

The partnership aims to address the technical setup challenges that plague meetings across the UK. Owl Labs’ recent State of Hybrid Work report found that nearly 8 in 10 workers (79%) lose time in meetings due to technical difficulties such as connecting to a meeting or setting up a camera. By making Owl Labs’ solutions simpler to source, deploy and support, the Westcoast partnership helps cut the ‘meeting tax’, reducing set‑up friction and getting meetings started on time.

The announcement follows the launch of the Meeting Owl 5 Pro earlier this year, Owl Labs’ newest 360-degree camera, speaker, and mic device. The Meeting Owl 5 Pro reimagines the centre-of-table experience for hybrid meetings with a solution purpose-built for enterprise organisations, delivering a seamless single-cable Bring Your Own Device (BYOD) experience. It is also now certified for Microsoft Teams, affirming that the device meets the highest standards demanded by IT leaders, ensuring optimal functionality within enterprise environments.

Westcoast, renowned for its strong vendor relationships and deep reseller network, will position Owl Labs’ products in its Unified Communications division alongside other leading collaboration technologies. This partnership expands Owl Labs’ footprint in the UK and Ireland, offering customers smooth access and faster delivery, while connecting partners with a trusted distributor deeply invested in video conferencing.

“Technology should not be a barrier to hybrid work,” said Frank Weishaupt, CEO, Owl Labs. “Our partnership with Westcoast represents a significant step in our UK growth strategy, aligning our products with a distributor that shares our dedication to customer success. Together, we are enabling seamless hybrid meetings, with technology that makes it easier than ever for organisations to build meeting spaces that work for everyone.”

Widening access to Owl Labs’ technology through Westcoast’s distribution network, including the newly-launched Meeting Owl 5 Pro and the award-winning Meeting Owl 4+, means that organisations can more easily create flexible, fully integrated meeting environments. In doing so, businesses can transform basic setups into seamless flexible ecosystems, allowing employees to focus on what really matters: communication and productivity.

“We are delighted to welcome Owl Labs to our Unified Communications portfolio,” said Sam Armstrong, Unified Communications Business Manager, Westcoast. “As demand for hybrid working continues to grow, our partners and customers are seeking reliable, intuitive solutions that drive productivity and collaboration. Owl Labs’ products are a perfect fit, and we look forward to working together to bring these market-leading solutions to businesses across the UK and Ireland.”

This agreement is non-exclusive and covers the full portfolio of Meeting Owl and Owl Bar devices. Owl Labs partners now have the choice to buy from Westcoast or the existing distribution channels. For more information on all Owl Labs products, visit owllabs.co.uk.

About Owl Labs

Owl Labs is the first company to build AI-powered, 360-degree video conferencing solutions for hybrid organisations. Its connected device system and Owl Intelligence System™ software make meetings more inclusive and collaborative by levelling the playing field between remote and in-room participants. The Meeting Owl® product line is the first AI-powered, WiFi-enabled, 360-degree camera, microphone and speaker that automatically zooms in on whoever’s speaking. Owl Labs has raised $47 million in funding and is based in Boston, with remote and hybrid employees all over the world. To learn more, visit www.owllabs.co.uk.

About Westcoast

Westcoast Limitedis the UK’s leading IT distributor, supplying a broad portfolio of hardware, software, and its own range of IT services to partners across the channel. The company works closely with vendors and resellers to deliver tailored solutions and drive innovation in the UK’s technology ecosystem. Further information can be found here: https://www.westcoast.co.uk/

Westcoast Limited and, all divisions, are part of ALSO Holding AG (ALSN.SW), Europe’s largest technology provider, giving partners access to a vast ecosystem of solutions, services and expertise, and extending its reach worldwide via PaaS partners.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260511571986/en/

Contacts

owluk@clarity.global

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

VerSprite Launches Fork and Knife: AI-Driven Threat Modeling and Adversarial Testing Built for the Speed of Modern Software26.6.2026 23:28:00 CEST | Press Release

VerSprite, a global leader in risk-based threat modeling and the firm behind the PASTA (Process for Attack Simulation and Threat Analysis) methodology, today announced the general availability of Fork (www.forktm.com), a continuous application threat modeling platform, alongside Knife, an AI-led, human-on-the-loop adversarial testing platform for web applications and web API endpoints. Together, the two products operationalize a new model for product security—one where applications are securely designed, continuously modeled, and actively tested as part of the build process itself. The launch addresses a problem every security leader knows but few tools have solved: threat modeling is essential, never more so than in an AI-driven era, yet it has remained slow, manual, and anchored to frameworks designed for a different threat landscape. The problem: threat modeling matters more than ever—and most tools are stuck in 2005 For two decades, application threat modeling has leaned heavily on

Venture Global Announces Closing of $1.5 Billion Senior Secured Vessel Financing Facility26.6.2026 22:30:00 CEST | Press Release

Venture Global, Inc. (NYSE: VG) announced today that its wholly-owned subsidiary, Venture Global Shipping Holdings, LLC (“VGSH”), has entered into a Credit and Guaranty Agreement providing for a senior secured term loan facility (the “Facility”) in an aggregate principal amount of up to $1,500,000,000. The Facility will mature on June 26, 2032. Deutsche Bank and ING acted as coordinating lead arrangers for the Facility. ING also serves as facility agent and security trustee. VGSH intends to use the net proceeds from the Facility for general corporate purposes, including to reimburse Venture Global LNG, Inc. for payments previously made by it or its affiliates in connection with the acquisition of nine LNG carriers, funding certain reserve accounts, and paying transaction fees and expenses. About Venture Global Venture Global is an American producer and exporter of low-cost U.S. liquefied natural gas (“LNG”) with over 100 MTPA of capacity in production, construction, or development. Ven

Capco Recognized by OpenAI for Innovation and Responsible AI Leadership26.6.2026 20:00:00 CEST | Press Release

Global management and technology consultancy Capco, a Wipro company,has been recognized by OpenAI for both AI innovation and responsible AI leadership. Capco received the AI Governance & Risk Excellence Award at the recent OpenAI Partner Summit 2026 in San Francisco, highlighting Capco’s ability to deliver enterprise-grade AI outcomes in highly regulated environments. The award recognizes Capco’s expert advantage when helping financial services and energy organizations to scale AI with confidence, balancing innovation with strong governance to reduce risk, strengthen compliance and improve customer outcomes. This award follows Capco winning the OpenAI Codex Hackathon, where its UK AI Lab competed against more than 30 teams and over 100 participants from across the OpenAI partner ecosystem. Capco's winning entry Sentra – a consulting-led, AI-powered retail banking solution – uses digital twin technology to identify vulnerable customers and recommend explainable next-best actions for fro

Incyte Announces Positive CHMP Opinion for Opzelura ® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press Release

Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. “AD is a chronic skin condition that can have a significant impact on daily life. The positive CHMP opinion for Opzelura marks meaningful progress toward bringing the first non-steroidal topical JAK treatment option to adults in Europe with moderate AD for whom standard topical therapies have failed,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved by the European Commission, Opzelura could help address an important gap for patients who have limited treatment options when TCSs and TCIs are inadequate or inappropriate.” The positive CHMP o

Datroway ® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press Release

Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast02phase 3 trial, which werepresented at the 2025 European Society for Medical Oncology Congress and published in Annals of Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast02, Datroway demonstrated a

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye